191 related articles for article (PubMed ID: 8204359)
1. Production of monoclonal antibodies recognising the peptide core of MUC2 intestinal mucin.
Durrant LG; Jacobs E; Price MR
Eur J Cancer; 1994; 30A(3):355-63. PubMed ID: 8204359
[TBL] [Abstract][Full Text] [Related]
2. Monoclonal antibodies reacting with the MUC2 mucin core protein.
Devine PL; McGuckin MA; Birrell GW; Whitehead RH; Sachdev GP; Shield P; Ward BG
Br J Cancer; 1993 Jun; 67(6):1182-8. PubMed ID: 8512804
[TBL] [Abstract][Full Text] [Related]
3. Heterogeneity of mucin gene expression in normal and neoplastic tissues.
Ho SB; Niehans GA; Lyftogt C; Yan PS; Cherwitz DL; Gum ET; Dahiya R; Kim YS
Cancer Res; 1993 Feb; 53(3):641-51. PubMed ID: 7678777
[TBL] [Abstract][Full Text] [Related]
4. Anti-peptide monoclonal antibodies to intestinal mucin 3.
Apostolopoulos V; Xing PX; McKenzie IF
J Gastroenterol Hepatol; 1995; 10(5):555-61. PubMed ID: 8963031
[TBL] [Abstract][Full Text] [Related]
5. Immunoreactivity of Lewis blood group and mucin peptide core antigens: correlations with grade of dysplasia and malignant transformation in the colorectal adenoma-carcinoma sequence.
Baldus SE; Hanisch FG; Pütz C; Flucke U; Mönig SP; Schneider PM; Thiele J; Hölscher AH; Dienes HP
Histol Histopathol; 2002 Jan; 17(1):191-8. PubMed ID: 11813869
[TBL] [Abstract][Full Text] [Related]
6. Expression of MUC1 and MUC2 mucins by human tumor cell lines.
Devine PL; Birrell GW; Whitehead RH; Harada H; Xing PX; McKenzie IF
Tumour Biol; 1992; 13(5-6):268-77. PubMed ID: 1283926
[TBL] [Abstract][Full Text] [Related]
7. Second-generation monoclonal antibodies to intestinal MUC2 peptide reactive with colon cancer.
Xing PX; Prenzoska J; Layton GT; Devine PL; McKenzie IF
J Natl Cancer Inst; 1992 May; 84(9):699-703. PubMed ID: 1569603
[TBL] [Abstract][Full Text] [Related]
8. Mucin gene expression in normal, preneoplastic, and neoplastic human gastric epithelium.
Ho SB; Shekels LL; Toribara NW; Kim YS; Lyftogt C; Cherwitz DL; Niehans GA
Cancer Res; 1995 Jun; 55(12):2681-90. PubMed ID: 7780985
[TBL] [Abstract][Full Text] [Related]
9. Oncofetal mucin M1 epitope family: characterization and expression during colonic carcinogenesis.
Bara J; Gautier R; Mouradian P; Decaens C; Daher N
Int J Cancer; 1991 Jan; 47(2):304-10. PubMed ID: 1988372
[TBL] [Abstract][Full Text] [Related]
10. Production of anti-breast cancer monoclonal antibodies using a glutathione-S-transferase-MUC1 bacterial fusion protein.
Apostolopoulos V; Xing PX; Trapani JA; McKenzie IF
Br J Cancer; 1993 Apr; 67(4):713-20. PubMed ID: 7682431
[TBL] [Abstract][Full Text] [Related]
11. Expression of MUC2 and MUC3 mRNA in human normal, malignant, and inflammatory intestinal tissues.
Weiss AA; Babyatsky MW; Ogata S; Chen A; Itzkowitz SH
J Histochem Cytochem; 1996 Oct; 44(10):1161-6. PubMed ID: 8813081
[TBL] [Abstract][Full Text] [Related]
12. A novel gastric-cancer-associated mucin antigen defined by a monoclonal antibody A3D4.
Akashi H; Hinoda Y; Itoh F; Adachi M; Endo T; Imai K
Int J Cancer; 1997 Dec; 73(6):795-801. PubMed ID: 9399654
[TBL] [Abstract][Full Text] [Related]
13. Altered mucin core peptide immunoreactivity in the colon polyp-carcinoma sequence.
Ho SB; Ewing SL; Montgomery CK; Kim YS
Oncol Res; 1996; 8(2):53-61. PubMed ID: 8859775
[TBL] [Abstract][Full Text] [Related]
14. Expression of epithelial mucins Muc1, Muc2, and Muc3 in ductal carcinoma in situ of the breast.
Diaz LK; Wiley EL; Morrow M
Breast J; 2001; 7(1):40-5. PubMed ID: 11348414
[TBL] [Abstract][Full Text] [Related]
15. Cystic fibrosis and pancreatic cancer cells synthesize and secrete MUC1 type mucin gene product.
Dahiya R; Kwak KS; Ho SB; Yoon WH; Kim YS
Biochem Mol Biol Int; 1995 Feb; 35(2):351-62. PubMed ID: 7545050
[TBL] [Abstract][Full Text] [Related]
16. Expression of MUC1, MUC2 and oligosaccharide epitopes in breast cancer: prognostic significance of a sialylated MUC1 epitope.
Baldus SE; Wienand JR; Werner JP; Landsberg S; Drebber U; Hanisch FG; Dienes HP
Int J Oncol; 2005 Nov; 27(5):1289-97. PubMed ID: 16211224
[TBL] [Abstract][Full Text] [Related]
17. Human colonic goblet cells. Demonstration of distinct subpopulations defined by mucin-specific monoclonal antibodies.
Podolsky DK; Fournier DA; Lynch KE
J Clin Invest; 1986 Apr; 77(4):1263-71. PubMed ID: 2420829
[TBL] [Abstract][Full Text] [Related]
18. Diverse glycosylation of MUC1 and MUC2: potential significance in tumor immunity.
Irimura T; Denda K; Iida Si; Takeuchi H; Kato K
J Biochem; 1999 Dec; 126(6):975-85. PubMed ID: 10578046
[TBL] [Abstract][Full Text] [Related]
19. Peptide binding sites recognized by anti-mucin (MUC2) monoclonal antibodies.
Xing PX; Apostolopoulos V; Prenzoska J; Devine PL; McKenzie IF
Scand J Immunol; 1993 Dec; 38(6):591-2. PubMed ID: 7504828
[TBL] [Abstract][Full Text] [Related]
20. Expression of MUC1 and MUC2 mucins in gastric carcinomas: its relationship with the prognosis of the patients.
Utsunomiya T; Yonezawa S; Sakamoto H; Kitamura H; Hokita S; Aiko T; Tanaka S; Irimura T; Kim YS; Sato E
Clin Cancer Res; 1998 Nov; 4(11):2605-14. PubMed ID: 9829723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
